Another study found that the ratio of NK cells to Lox-1+ PMN-MDSCs was also an ideal biomarker for PD-1 antibody treatment of NSCLC (Youn et al., 2020). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.